Escolar Documentos
Profissional Documentos
Cultura Documentos
8676/2016/01-02 Appendix 1
Leaflet
Official stamp: Ministry of Health
National Agency of Medicines and Medical Devices
Chairman
Read carefully and entirely this leaflet before using this drug, because it contains
important information for you
- Keep this leaflet. You might need to read it once again.
- If you have any other further questions, contact your doctor or pharmacist.
- This drug was prescribed only for you. You should not give it to other persons. It
might harm them, even if they manifest the same symptoms as you do.
- If you notice any side effects, contact your doctor or pharmacist. This includes any
possible side effects not specified in the present leaflet. See section 4.
1
- if you have established heart disease and/or cerebrovascular disease e.g. if you have
had a heart attack, mini-stroke (TIA) or blockages to blood vessels to the heart or
brain or an operation to clear or bypass blockages;
- if you have or have had problems with your blood circulation (peripheral arterial
disease).
Make sure your doctor knows these before you are given diclofenac:
- if you are smoking
- if you have diabetes
- if you have angina, blood clots, high blood pressure, raised cholesterol or raised
triglycerides.
Side effects may be minimized by using the lowest effective dose for the shortest duration
necessary for controlling the symptoms.
It is necessary to estimate the therapeutic risk/benefit ratio in the event of liver and renal
failure (risk of increased toxicity from drug accumulation).
Caution is required in surgical interventions because of the increased risk of bleeding.
Medicines as Diclofenac Helcor can be associated with a slightly high risk of myocardial
infarction or stroke occurrence. Risks of any kind are more likely to occur when administered
at high doses and in long-term treatment. Do not exceed the dosage and the term prescribed
for the specific treatment.
If you suffer from heart diseases or have a stroke in your history, or consider you might put
yourself in a risky situation due to the above mentioned diseases (e.g. if you suffer from high
blood pressure, diabetes mellitus, high values of cholesterol or if you are a smoker), you
should discuss about your treatment with your doctor or with your pharmacist.
Elderly
Careful monitoring of patients is required in this age group. Lower doses than usual should be
used since the elimination of diclofenac is low in impaired liver function or renal failure. The
risk of gastrointestinal toxicities is high.
2
- acetylsalicylic acid it decreases the plasma concentration of diclofenac;
- glucocorticoids risk of ulcerations and digestive bleeding;
- coumarin oral anticoagulants risk of bleeding (prothrombin time should be
monitored and dosage adjusted);
- heparins risk of bleeding;
- ticlopidine and other platelet aggregation inhibitors (it causes an increase of the risk of
bleeding);
- thrombolytic agents: alteplase, streptokinase (risk of bleeding);
- lithium it increases its plasma concentration (risk of toxicity);
- methotrexate it increases the hematologic toxicity;
- diuretics diclofenac can reduce the natriuretic effect of furosemide and thiazides,
risk of hyperpotassemia in combination with antialdosteronic diuretics; renal failure
may occur, requiring close monitoring of patients;
- angiotensin-converting enzyme inhibitors: diclofenac can diminish their
antihypertensive effect;
- antihypertensive drugs disposition to water and salt retention in body (the treatment
monitoring is necessary);
- beta-blockers: they decrease the antihypertensive effect;
- digoxin it increases its plasma concentration in blood and the toxic risk; (the
treatment has to be monitored);
- cyclosporine, gold compounds, nephrotoxic medication it increases the plasma
concentration and the nephrotoxic effects;
- zidovudine a high risk of hematologic toxicity;
- photosensitizing medication additive photosensitizing effects appear.
Your doctor will inform you about the medicines that require special attention in the event of
combined administration with Diclofenac Helcor or the drugs that must be avoided.
Pregnancy
Ask your doctor or pharmacist for advice before taking any medicine during pregnancy.
Do not use Diclofenac Helcor if you are in the last 4 months of pregnancy.
Diclofenac has a toxic effect on the heart and lungs (premature closure of the arterial duct)
and kidneys of the unborn child.
It extends labor.
Breastfeeding
Do not use Diclofenac Helcor if you breastfeed (it is excreted in small amounts into breast
milk). If its administration in more consecutive doses is absolutely necessary, breast-feeding
must be avoided.
3
Driving vehicles and using machineries
The use of Diclofenac Helcor requires caution, because the effects on the central nervous
system may alter the ability to drive or operate machinery.
4
- Other reactions: affecting the renal function, dizziness, edema, cephalalgia, transitory
rash, tinnitus, anemia, increase of the liver enzymes, increased bleeding time.
5
Reporting of adverse reactions
If any side effects occur, ask your doctor or pharmacist. This includes any side effects not
listed in this leaflet. Also, you can report adverse reactions via the national reporting system,
the details of which are published on the website of the National Agency of Medicines and
Medical Devices http://www.anm.ro. Reporting side effects you can help provide more
information on the safety of this drug.
Do not take Diclofenac Helcor after the expiry date written on its package, after EXP. The
expiry date refers to the last day of that month.
Medicines should not be disposed via wastewater or household waste. Ask your pharmacist
how to dispose of medicines no longer required. These measures will help protect the
environment.
Manufacturer
S.C. AC HELCOR SRL
62 Victor Babe street, Baia-Mare, county of Maramure, Romania
For any information about this medicine, please contact the local representative of the
marketing authorization holder.